N-[(3-methoxyphenyl)methyl]butan-1-amine | 60983-81-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-[(3-methoxyphenyl)methyl]butan-1-amine
• CAS: 60983-81-5
• 化学式: C₁₂H₁₉NO
• mdl: MFCD07405674
• 分子量: 193.28
• InChiKey: YWAIQZVYGOQBMO-UHFFFAOYSA-N

物化性质

• 熔点：
  98-100°C

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39,S45
• 危险类别码：
  R34
• 海关编码：
  2928000090
• 危险品运输编号：
  UN 3261

SDS

Name:	2-(Hydroxyamino)-2-methylpropanal oxime 97% Material Safety Data Sheet
Synonym:
CAS:	60983-81-5

Section 1 - Chemical Product MSDS Name:2-(Hydroxyamino)-2-methylpropanal oxime 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
60983-81-5	2-(Hydroxyamino)-2-methylpropanal oxim	97%	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 60983-81-5: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 98 - 100 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C4H10N2O2
Molecular Weight: 118

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, bases, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 60983-81-5 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-(Hydroxyamino)-2-methylpropanal oxime - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.*
Hazard Class: 8
UN Number: 3259
Packing Group: III
IMO
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing Group: III
RID/ADR
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 60983-81-5: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 60983-81-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 60983-81-5 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

文献信息

• FLAVIN DERIVATIVES
  申请人：Blount Kenneth F.

  公开号：US20120295903A1

  公开（公告）日：2012-11-22

  The present invention relates novel flavin derivatives and other flavin derivatives, their use and compositions for use as riboswitch ligands and/or anti-infectives. The invention also provides method of making novel flavin derivatives.

  本发明涉及新型黄素衍生物和其他黄素衍生物，它们的用途和组合物用作核糖开关配体和/或抗感染剂。本发明还提供制备新型黄素衍生物的方法。
• PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE
  申请人：Guibourt Nathalie

  公开号：US20120004262A1

  公开（公告）日：2012-01-05

  The present invention relates to phenylcyclopropylamine derivatives. In particular, pharmaceutical compositions comprising phenylcyclopropylamine derivatives are provided. The compounds of this invention can, inter alia, be used for the treatment and the prevention of cancer as well as neurodegenerative diseases or disorders.

  本发明涉及苯基环丙胺衍生物。具体而言，本发明提供了含有苯基环丙胺衍生物的药物组合物。本发明的化合物可以用于治疗和预防癌症以及神经退行性疾病或紊乱等方面。
• Process for the production of isoindoline derivatives, novel intermediates and process for their production
  申请人：Banyu Pharmaceutical Co., Ltd.

  公开号：EP0275064A2

  公开（公告）日：1988-07-20

  A process for producing a compound of the formula: wherein R¹ is a hydrogen atom, a lower alkyl group or an aralkyl group, and R² is a hydrogen atom or a hydroxyl-protecting group, or a salt thereof, which comprises removing from a compound of the formula: wherein R³ is a hydrogen atom or a hydroxyl-protecting group, R⁴ and R⁵ which may be the same or different are N-protecting groups selected from the group consisting of lower alkyl groups and aralkyl groups, and X⊖ is an anion, the N-protecting group(s), if necessary, together with the hydroxyl-protecting group.

  一种生产式化合物的工艺： 其中R¹为氢原子、低级烷基或芳烷基，R²为氢原子或羟基保护基，或其盐的工艺，包括从式化合物中除去 其中 R³ 是氢原子或羟基保护基团，R⁴ 和 R⁵ 可以相同或不同，是选自由低级烷基和芳烷基组成的组的 N 保护基团，X⊖ 是阴离子。
• Therapeutic compounds
  申请人：ZENECA LIMITED

  公开号：EP0709376A2

  公开（公告）日：1996-05-01

  Compounds of formula I wherein Q¹, Q, Q³, and Q⁴, Q⁵ have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of SP and NKA are useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.

  式 I 的化合物 其中 Q¹、Q、Q³ 和 Q⁴、Q⁵ 具有说明书中给出的任何含义，它们的 N-氧化物及其药学上可接受的盐是 SP 和 NKA 的非肽拮抗剂，可用于治疗哮喘等。还公开了药物组合物、制备式 I 化合物的工艺和中间体。
• Phenylpiperidino derivatives as neurokinin antagonists
  申请人：AstraZeneca AB

  公开号：EP0709376B1

  公开（公告）日：2003-07-23